News
Find the latest news and press releases of LFB Group and its companies
Enrollment of the 1st patient in phase III trial for an anti-COVID19 hyperimmune medicine
Back in details on the deep strategic transformation of LFB in "Pharmaceutiques" september 2020
Presentation of the PRISM Study Results During the LFB Symposium at the ICNMD Virtual Congress
LFB at the side of the Armed Forces for more than 5 years
LFB symposium at the ISTH virtual congress on July 14th
Visit of the future LFB manufacturing site in Arras
Presentation of PRISM study posters at the PNS virtual congress on 27 June 2020
Scientific publications for LFB
LFB SIGNS AGREEMENT WITH XENOTHERA TO MANUFACTURE FIRST CLINICAL BATCH OF XENOTHERA'S XAV-19 FOR THE TREATMENT OF CORONAVIRUS INFECTIONS INCLUDING COVID-19